A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility

Abstract Objectives We aimed to present the state of the art of CT- and MRI-based radiomics in the context of ovarian cancer (OC), with a focus on the methodological quality of these studies and the clinical utility of these proposed radiomics models. Methods Original articles investigating radiomic...

Full description

Bibliographic Details
Main Authors: Meng-Lin Huang, Jing Ren, Zheng-Yu Jin, Xin-Yu Liu, Yong-Lan He, Yuan Li, Hua-Dan Xue
Format: Article
Language:English
Published: SpringerOpen 2023-07-01
Series:Insights into Imaging
Subjects:
Online Access:https://doi.org/10.1186/s13244-023-01464-z
_version_ 1797784584956411904
author Meng-Lin Huang
Jing Ren
Zheng-Yu Jin
Xin-Yu Liu
Yong-Lan He
Yuan Li
Hua-Dan Xue
author_facet Meng-Lin Huang
Jing Ren
Zheng-Yu Jin
Xin-Yu Liu
Yong-Lan He
Yuan Li
Hua-Dan Xue
author_sort Meng-Lin Huang
collection DOAJ
description Abstract Objectives We aimed to present the state of the art of CT- and MRI-based radiomics in the context of ovarian cancer (OC), with a focus on the methodological quality of these studies and the clinical utility of these proposed radiomics models. Methods Original articles investigating radiomics in OC published in PubMed, Embase, Web of Science, and the Cochrane Library between January 1, 2002, and January 6, 2023, were extracted. The methodological quality was evaluated using the radiomics quality score (RQS) and Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). Pairwise correlation analyses were performed to compare the methodological quality, baseline information, and performance metrics. Additional meta-analyses of studies exploring differential diagnoses and prognostic prediction in patients with OC were performed separately. Results Fifty-seven studies encompassing 11,693 patients were included. The mean RQS was 30.7% (range − 4 to 22); less than 25% of studies had a high risk of bias and applicability concerns in each domain of QUADAS-2. A high RQS was significantly associated with a low QUADAS-2 risk and recent publication year. Significantly higher performance metrics were observed in studies examining differential diagnosis; 16 such studies as well as 13 exploring prognostic prediction were included in a separate meta-analysis, which revealed diagnostic odds ratios of 25.76 (95% confidence interval (CI) 13.50–49.13) and 12.55 (95% CI 8.38–18.77), respectively. Conclusion Current evidence suggests that the methodological quality of OC-related radiomics studies is unsatisfactory. Radiomics analysis based on CT and MRI showed promising results in terms of differential diagnosis and prognostic prediction. Critical relevance statement Radiomics analysis has potential clinical utility; however, shortcomings persist in existing studies in terms of reproducibility. We suggest that future radiomics studies should be more standardized to better bridge the gap between concepts and clinical applications. Graphical abstract
first_indexed 2024-03-13T00:41:59Z
format Article
id doaj.art-d4bc642efa9245d1b60fb4557f1a5187
institution Directory Open Access Journal
issn 1869-4101
language English
last_indexed 2024-03-13T00:41:59Z
publishDate 2023-07-01
publisher SpringerOpen
record_format Article
series Insights into Imaging
spelling doaj.art-d4bc642efa9245d1b60fb4557f1a51872023-07-09T11:15:46ZengSpringerOpenInsights into Imaging1869-41012023-07-0114111910.1186/s13244-023-01464-zA systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utilityMeng-Lin Huang0Jing Ren1Zheng-Yu Jin2Xin-Yu Liu3Yong-Lan He4Yuan Li5Hua-Dan Xue6Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical CollegeDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical CollegeDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical CollegeDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical CollegeDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical CollegeDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Obstetric & Gynecologic DiseasesDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical CollegeAbstract Objectives We aimed to present the state of the art of CT- and MRI-based radiomics in the context of ovarian cancer (OC), with a focus on the methodological quality of these studies and the clinical utility of these proposed radiomics models. Methods Original articles investigating radiomics in OC published in PubMed, Embase, Web of Science, and the Cochrane Library between January 1, 2002, and January 6, 2023, were extracted. The methodological quality was evaluated using the radiomics quality score (RQS) and Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). Pairwise correlation analyses were performed to compare the methodological quality, baseline information, and performance metrics. Additional meta-analyses of studies exploring differential diagnoses and prognostic prediction in patients with OC were performed separately. Results Fifty-seven studies encompassing 11,693 patients were included. The mean RQS was 30.7% (range − 4 to 22); less than 25% of studies had a high risk of bias and applicability concerns in each domain of QUADAS-2. A high RQS was significantly associated with a low QUADAS-2 risk and recent publication year. Significantly higher performance metrics were observed in studies examining differential diagnosis; 16 such studies as well as 13 exploring prognostic prediction were included in a separate meta-analysis, which revealed diagnostic odds ratios of 25.76 (95% confidence interval (CI) 13.50–49.13) and 12.55 (95% CI 8.38–18.77), respectively. Conclusion Current evidence suggests that the methodological quality of OC-related radiomics studies is unsatisfactory. Radiomics analysis based on CT and MRI showed promising results in terms of differential diagnosis and prognostic prediction. Critical relevance statement Radiomics analysis has potential clinical utility; however, shortcomings persist in existing studies in terms of reproducibility. We suggest that future radiomics studies should be more standardized to better bridge the gap between concepts and clinical applications. Graphical abstracthttps://doi.org/10.1186/s13244-023-01464-zOvarian neoplasmsDifferential diagnosisMachine learningSystematic review
spellingShingle Meng-Lin Huang
Jing Ren
Zheng-Yu Jin
Xin-Yu Liu
Yong-Lan He
Yuan Li
Hua-Dan Xue
A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility
Insights into Imaging
Ovarian neoplasms
Differential diagnosis
Machine learning
Systematic review
title A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility
title_full A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility
title_fullStr A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility
title_full_unstemmed A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility
title_short A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility
title_sort systematic review and meta analysis of ct and mri radiomics in ovarian cancer methodological issues and clinical utility
topic Ovarian neoplasms
Differential diagnosis
Machine learning
Systematic review
url https://doi.org/10.1186/s13244-023-01464-z
work_keys_str_mv AT menglinhuang asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT jingren asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT zhengyujin asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT xinyuliu asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT yonglanhe asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT yuanli asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT huadanxue asystematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT menglinhuang systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT jingren systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT zhengyujin systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT xinyuliu systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT yonglanhe systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT yuanli systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility
AT huadanxue systematicreviewandmetaanalysisofctandmriradiomicsinovariancancermethodologicalissuesandclinicalutility